EORTC abstracts at ESMO 2018
15 Oct 2018
Results from a number of EORTC trials will be presented at ESMO2018 Congress in Munich, please see below the title and presenters of the presentations:
Oral Presentation
- An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23)- EORTC QLQ-BR45
Presentation Number: 193O
Tumour Group: Quality of Life
Speaker: Vesna Bjelic-Radisic (Germany)
Date: 20.10.2018 – Lecture Time: 11:00 – Location: Hall A2 – Room 18
Poster Discussion
- A randomised phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC – the ETOP and EORTC SPLENDOUR trial.
Presentation Number 1385PD
Tumour Group: Lung
Poster Presenter: Solange Peters (Switzerland)
Date: 21.10.2018 – Lecture Time 17:15 – Location: ICM – Room 13
- Health-related quality of life in randomized controlled trials: a systematic review of prognostic significance
Presentation Number: 1540PD
Tumour Group: Quality of Life
Speaker: Justyna Mierzynska (Belgium)
Date: 22.10.2018 – Lecture Time: 16:30 – Location: Hall B3 – Room 21
Poster Display Session
- Treatment patterns in elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC): results from an EORTC led survey
Poster Board Number: 1106P
Tumour Group: Head & Neck
Poster Presenter: Sjoukje Oosting (The Netherlands)
Date: 21.10.2018 – Lecture Time: 13:05 – 13:05 – Location: Hall A3 – Poster Area Networking Hub
- Combined analysis of gene expression profiles in 2 preoperative trials with afatinib and cetuximab in head and neck squamous cell carcinoma
Poster Board Number: 1086P
Tumour Group: Head & Neck
Poster Presenter: Paolo Bossi (Italy)
Date: 21.10.2018 – Lecture Time: 13:05 – Location: Hall B3 – Poster Area
- Health-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: an international randomized double-blind phase 3 trial.
Poster Board Number: 1278P
Tumour Group: Quality of Life
Poster Presenter: Corneel Coens (Belgium)
Date: 21.10.2018 – Lecture Time: 13:05 – Location: Hall B3 – Poster Area
Related News
New European AI assistant to make patient experiences actionable for care and health systems
12 Nov 2026
First site activated in EORTC STARBURST-1, the research project on muscle-invasive bladder cancer
28 Oct 2026
EORTC at ESMO 2026: New findings and ongoing studies
27 Oct 2026
EORTC research presented at ESMO 2026
22 Oct 2026
EORTC Quality of Life Group at ISOQOL 2026
15 Oct 2026
Pink October 2026: Advancing breast cancer research, together
7 Oct 2026
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
